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Abbreviations and Acronyms  
ANC   Antenatal care  
ART   Antiretroviral therapy  
CBD   Community-based distribution  
CCT   Conditional cash transfer  
CHW   Community health worker  
CVR   Contraceptive vaginal ring  
DHS   Demographic and Health Survey  
EC   Emergency contraception  
ehealth  Electronic communication technology, such as computers and mobile phones,  
used for health services and information  
FC   Female condom  
FP   Family planning  
HIV   Human immunodeficiency virus  
HMIS   Health management information system  
IUD   Intrauterine device  
LAM   Lactational amenorrhea method  
M&E   Monitoring and evaluation  
mhealth  Mobile communication technology used in health care delivery systems  
PAC   Postabortion care  
PBF   Performance-based financing  
PLWHA  People living with HIV/AIDS  
RCT   Randomized controlled trial  
RH   Reproductive health  
SBCC   Social and behavior change communication  
SDM   Standard Days Method  
TBA   Traditional Birth Attendant  
TM   Total market  
UNDP  United Nations Development Programme  
UNFPA  United Nations Population Fund  
WHO   World Health Organization 
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INTRODUCTION  
“The evidence is clear: Family planning improves health, reduces poverty, and empowers women” 
(Bongaarts et al. 2012). Voluntary high-quality family planning programs speed fertility declines, thus 
improving health and boosting economies. Indeed, they are among the most cost-effective health and 
development investments available to governments (Bongaarts et al. 2012; Cleland et al. 2006). The case 
for family planning has been made, yet more than 200 million women in the developing world who want 
to avoid pregnancy are not using a modern contraceptive method. The reasons for this are many, 
including lack of access to information and appropriate health services, traditional gender norms that 
impede women’s ability to adopt contraception, community and gatekeepers’ (husband, in-laws, partners) 
opposition, real and perceived concerns about safety and side effects, and cost, among others. 
Underlying socio-behavioral issues, including risk perception, ambivalence, and social costs, may also 
play a role in demand and use.  
An Opportune Moment  
After a decade of waning investment in family planning (FP), we are now witnessing a resurgence of 
interest and funding. This is an opportune moment to address the unfinished family planning agenda 
(Cleland et al. 2006). The International Family Planning Summit held in London in July 2012 witnessed 
unprecedented levels of financial and political commitment from national governments and the 
international community to achieve the goal of 120 million new users of contraceptives by 2020. This 
goal is to be achieved through a coordinated effort, known as FP2020, through implementing four broad 
objectives:  
 Increase political commitment and accountability for delivery of family planning services 
 Contribute to substantially increased access to family planning information, services, and 
supplies 
 Create a healthy and sustainable market for family planning commodities 
 Adapt and develop new and innovative contraceptive methods 
 
This paper is intended to help guide discussions and considerations regarding the key evidence gaps and 
research investments needed to achieve the FP2020 goal and objectives. The paper focuses primarily on 
the social science, implementation, and operations research that will be needed to achieve the first three 
objectives. The contraceptive research and development (R&D) needed for the fourth objective is the 
subject of another initiative.  
What We Know  
Simply stated, we know that the most effective approach to achieving the FP2020 goal is to ensure 
universal access to family planning, so that all women have access to a full range of effective, acceptable, 
and affordable contraceptive methods appropriate to their needs and situation, made available through 
multiple service delivery channels in a reliable fashion. Achieving this, however, requires political will, 
human and economic resources, technical expertise, vision, and leadership. Context also matters. The 
diversity of needs, populations, and reproductive intentions of individuals and couples, along with the 
maturity of programming and the strength of particular national health systems, will influence the 
effectiveness and impact of investments in FP2020.  
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Research on family planning has made great strides in generating evidence about how it improves lives 
through reducing adverse health outcomes associated with unintended pregnancy, reducing poverty by 
facilitating economic development and improving women’s and girls’ social status. As the availability and 
use of FP information and services have increased over the past three decades, however, so has the need 
for evidence-based policy guidance, as well as evidence-based strategies for programming and financing. 
Moreover, the degree to which strategies and best practices proven through small-scale projects can be 
and have been scaled up within national health systems is not well understood.  
The design and implementation of FP services over this period has benefited from donor investments in 
social science, implementation, and operations research that has generated a substantial body of 
evidence, some of which is context-specific but much of which can be generalized across social milieu 
and health systems (Jacobstein et al. 2013). This paper reviews the evidence base to identify what is 
currently known about FP services and what evidence gaps still exist for which further investments in 
research will be critical for informing the design, implementation and evaluation of FP2020 initiatives.  
METHODOLOGY  
Given the scale and diversity of the evidence base, we initially identified a number of rigorous literature 
reviews that have been conducted on the topic and published within the past five years. Where 
appropriate, other key documents with relevant evidence were gleaned from reviews and informed 
experts (Jacobstein et al. 2013). In addition, the recent World Health Organization (WHO) prioritization 
exercises (Ali et al. 2012; Hindin et al. 2013)and USAID’s ‘High Impact Practices’ (HIP) documents 
(K4Health 2012) were reviewed. Several systematic reviews, some following the Cochrane review 
methodology, were also identified. From these reviews, and drawing from expert informants and our 
own experience, we identified documentary sources that were considered to present research-based 
evidence of sufficient quality and rigor to be included. We included reviews that reported evidence 
generated through a range of research methods (demographic, social science, epidemiologic, policy 
analysis, and implementation science/operations research) and excluded evidence from biomedical, 
clinical trials, and other product development research. The evidence was collected and collated 
according to a theory of change framework.  
Theory of Change Framework  
Numerous frameworks exist for conceptualizing the determinants and consequences of contraceptive 
use dynamics. We approached this review and analysis through the lens of a theory of change comprising 
five critical and interrelated elements:  
 Social determinants of FP demand and use 
 Health system determinants  
 Demand and use dynamics  
 Associations between FP use, non-use, and distal outcomes  
 Research, monitoring, and evaluation  
 
Based on this theory of change, and in consultation with the expert informants, we prepared a detailed 
list of topics and assigned them to the appropriate elements in a Review Framework that guides the 
presentation of the summary of evidence below.  
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Evidence from the Review  
Social Determinants of FP Demand and Use  
Many social determinants can influence demand for and use of FP, either individually or in various 
combinations. In developing countries, the most influential determinants are typically: girls’ and women’s 
social status and decision-making power; level of education; marital status; economic status; age; place of 
residence; and experience of violence (Bongaarts et al. 2012; Cleland et al. 2006; Creanga et al. 2011; 
Gillespie et al. 2007; Malarcher et al. 2011; DFID 2010b; DFID 2010a; Ortayli and Malarcher 2010). In 
some settings, ethnicity, migrant status, and HIV status can also be key determining factors. The role of 
these social determinants in shaping demand for and use of FP is well documented (Cleland et al. 2006; 
DFID 2010b), and evidence from multiple settings and populations exists that can be used to advocate 
for the importance of understanding which factors are the most influential in determining demand and 
use in a particular setting, and, in turn, for identifying those populations that are the most underserved 
and have the highest unmet need.  
Framing this evidence from an equity perspective is critically important so as to focus policy and 
programmatic attention on identifying the most disadvantaged, vulnerable, and underserved 
populations with unmet need (Creanga et al. 2011; Gillespie et al. 2007). Reducing inequities in access 
and use are central to implementing a rights-based approach to providing FP services and inherent in 
the goal of MDG 5B: achieving universal access to reproductive health (RH), including family 
planning. Inequity reduction is also central to FP2020’s focus on rights and empowerment.  
 
The extent to which social determinants interact and influence demand for, access to, and use of FP 
services, and consequently contribute to inequities, is highly context-and population-dependent. Situation-
specific analyses should thus be undertaken to generate evidence for guiding rights-based policy/program 
development in all countries (Ortayli and Malarcher 2010). For example, most, but not all, Demographic 
and Health Surveys (DHS) include standard indicators for many of the social determinants and thus 
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provide an easily accessible data source (Malarcher et al. 2011; Ortayli and Malarcher 2010). Most of the 
evidence on social determinants comes, however, from cross-sectional surveys, such as the DHS, whereas 
longitudinal data could better demonstrate causality. Numerous demographic surveillance systems (DSS), 
which collect longitudinal data on a range of health indicators, exist in developing countries, but 
unfortunately very few routinely collect data on contraceptive use and fertility.  
Although the DHS can provide much useful data for an overall understanding of many social 
determinants of unmet need and unintended pregnancy, it generally lacks sufficient data to enable a full 
understanding of unmet need among key populations suffering from social inequities, notably married 
and unmarred adolescents, marginalized ethnic populations, urban slum dwellers, and people living with 
HIV/AIDS (PLWHA). Because the adverse health, social, and economic outcomes of unintended 
pregnancies among these populations are generally more serious than among other populations 
(Gipson, Koenig and Hindin 2008; Malarcher et al. 2011), in-depth analyses of vulnerable populations 
are essential to generate evidence for rights-based policy and program development.  
Although the evidence of population-level associations is fairly strong and convincing (DFID 2010b), 
evaluated interventions that explicitly seek to address the underlying determinants that lead to inequities 
in access to and use of FP are relatively scarce (DFID 2010b; DFID 2010a). This is primarily because 
such “structural” interventions are usually implemented with the goal of broader social change and 
require large-scale complex interventions that may or may not explicitly include changes in reproductive 
intentions and contraceptive use. However, structural interventions are emerging that are intended to 
have a direct impact on access to and use of FP among populations suffering from specific inequities. 
Examples include reaching unmarried adolescents with appropriate information and services, reducing 
early marriage and reaching married adolescents with supportive information and services, reducing 
poverty-induced barriers, and reaching PLWHA. Evidence gaps persist in how to tackle these 
determinants, as well as for interventions that address: i) violence reduction and contraceptive use, 
especially for adolescent girls; ii) unintended pregnancy among populations living in urban slums, 
especially adolescents; and iii) girls and women engaged in sex work.  
Adolescents are a diverse group of 10-19 year olds whose capacities and needs differ by age, sex, living 
arrangements, area of residence, level of education, and by their marital, childbearing, and employment 
status. Given this heterogeneity, addressing adolescent RH needs presents complex challenges. 
Although some trends in adolescent health and social outcomes have improved over the past three 
decades—including school enrollment and retention, early marriage, and early pregnancy (WHO 
2011)—disparities in many adolescent health outcomes persist by age, income, gender, region, and 
other socio-cultural factors.  
Interventions seeking to reduce sexual risk-taking among adolescents have become increasingly common 
in developing countries in the past decade. These interventions have taken a variety of configurations, 
from conventional sex education in schools to multi-component, cross-sector efforts aimed at improving 
educational and economic opportunities and delaying marriage. Relatively few of these have been 
rigorously evaluated; and the majority of programs that have been evaluated are small in scale and 
implemented over a relatively brief period. There is a paucity of information concerning intervention 
costs, and little evidence regarding long-term behavioral effects (Speizer, Magnani and Colvin 2003).  
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Key determinants of adolescent pregnancy include early marriage, sexual coercion, and lack of access to 
and use of appropriate contraceptives. A recent systematic review (Lee-Rife et al. 2012) found little 
evidence concerning the effect of various non-health interventions on unintended pregnancy, and the 
evidence that does exist is generally weak. As a result, WHO made several research recommendations: i) 
assess the impact of improved educational availability on age of marriage; ii) assess the feasibility and 
long-term impact of economic incentives to girls and their families as a means of delaying age of 
marriage; iii) determine the effect of formal and non-formal education on adolescent pregnancy 
prevention; and iv) determine the effect of school-retention interventions (e.g., conditional or 
unconditional cash-transfer interventions) on delaying pregnancy. For addressing coerced sex, WHO 
recommends engaging men and boys to alter gender norms and normative behaviors, and highlights the 
need for research to assess how laws and policies to prevent coerced sex have been formulated, 
enforced, and monitored and to determine the effectiveness of these laws and policies in preventing 
coerced sex among adolescents.  
Awareness of FP and Contraceptive Technologies  
Raising awareness of the benefits of preventing unintended pregnancies and thereby enabling 
individuals and couples to plan “children by choice not chance” through using contraceptive 
technologies has a long history (Bongaarts et al. 2012; DFID 2010a). A substantial evidence base exists 
regarding the use of information, education, and communication (IEC) and social and behavior change 
communications (SBCC) strategies to generate demand for FP generally, and (to a lesser extent) for 
specific groups of contraceptive technologies (e.g., long-acting reversible methods, male methods, etc.).  
Four broad categories of demand generation interventions can be considered. Evidence from quasi-
experimental designs indicates that mass media campaigns can generate an immediate demand for FP 
services and are associated with approval of FP and greater partner communication about FP and 
increased contraceptive use. “Edutainment” programs through radio and TV dramas are associated with 
increased contact with FP providers, greater use of FP, and decreased desired family size (Bongaarts et 
al. 2012; Mwaikambo et al. 2011; Westoff, Koffman and Moreau 2011). Community mobilization 
approaches are usually implemented jointly with service delivery through community health worker 
(CHW) programs or social marketing programs, both of which have been found to have substantial 
effects on the demand for and use of FP (DFID 2010a). Evidence also supports the effectiveness of 
interventions that increase interpersonal communications, especially between young people, 
partners/couples, other family members, or social peers (DFID 2010a; Mwaikambo et al. 2011). Recent 
developments in mhealth for generating FP demand have stimulated much interest, and several pilot 
projects are currently underway, but little evidence exists because results have not yet been published 
(L’Engle 2012).  
Because vulnerable populations are generally more isolated, poorer and less literate, they are also less 
likely to be exposed to many of these demand generation interventions (Ortayli and Malarcher 2010). 
Moreover, the relevance, or perceived relevance, of these messages may be particularly low for 
vulnerable populations, for example married girls and female sex workers. The extent to which 
vulnerable populations are reached by these types of interventions and the extent to which the 
interventions have an effect on such populations remain under-researched and should be highlighted 
in future evaluations of demand generation interventions. Social marketing organizations are often 
required to report on the extent to which their campaigns reach the poorest and most vulnerable 
populations, and such analyses should be integral to the design and evaluation of future demand 
generation interventions.  
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Reducing unmet need is the primary goal of FP2020. Focusing on reducing unmet need implicitly 
assumes that a demand for FP already exists and is being partially met. However, although awareness 
of the benefits of FP are widely known in most regions of the world (apart from West Africa), 
knowledge of contraceptive technologies and how to obtain them is often incomplete and inaccurate. 
Thus, unfounded concerns regarding side effects are widespread, contributing to personal and partner 
opposition to contraception (Darroch, Sedgh and Ball 2011). Strategic communication strategies 
(Bongaarts et al. 2012) are therefore still needed within the FP2020 framework, especially for 
populations without full awareness of the range of contraceptive alternatives available, how they 
function, and how to access them. The evidence base regarding interventions tailored to address 
method-related concerns is thin, however.  
 
Health System Determinants  
National health systems largely (but not solely) determine the institutional structures and processes 
through which FP is delivered and accessed. When considering a national health system, it is important 
to consider these systems from the perspective of the “total market” (TM) through which FP is made 
available, which includes public, commercial, not-for-profit, and faith-based sectors (Barnes et al. 2012). 
To organize the evidence available concerning FP delivery through a total market health system, we 
adopt the framework of WHO’s six “building blocks” of health systems: service delivery, human 
resources, systems information, medicines, financing, and leadership and governance.  
Service Delivery 
Globally, the number and type of service delivery channels through which FP is delivered has increased 
dramatically over the past two decades, reflecting both expansion within the public sector and the 
growth of other sectors as sources of FP. To simplify the presentation of evidence, we cluster these 
into seven broad channels: clinic-based; integrated with other services; community-based; mobile 
outreach; social marketing and pharmacies; adolescent-friendly services; and other vulnerable 
populations.  
Clinic-based. Clinic-based delivery of FP services is still the main delivery channel for married women; 
increasingly, this may be through non-public sector facilities as the private sector grows in many 
countries. How to provide clinic-based FP services is broadly understood. The evidence challenges 
primarily concern improving quality and choice. The key components of high-quality services are well-
established, as described in the Bruce–Jain framework (Bruce 1990; Jain 2001), and substantial evidence 
exists that strengthening these components does impact client-provider interactions, client satisfaction, 
and effective and sustained method use (RamaRao and Mohanam 2003). Numerous quality improvement 
interventions have been developed, but relatively few have been rigorously evaluated (Mwaikambo et al. 
2011; RamaRao and Mohanam 2003). A recent synthesis of the evidence (Jain 2012) yielded two broad 
conclusions: (a) increasing the number of methods made available to clients increases choice, which leads 
to more new users, reduced discontinuation through switching, and increased prevalence overall; and (b) 
improving providers’ skills and attitudes enhances their technical competence and ability to identify and 
meet clients’ individual needs. The evidence base for which interventions can most efficiently increase 
the number of methods offered, and which can most effectively improve providers’ skills, particularly in 
counseling new clients to determine and meet their individual needs, including continued use of 
hormonal methods, remains limited, however (Cleland et al. 2006; Halpern et al. 2011; RamaRao and 
Mohanam 2003).  
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Evidence is also limited regarding the feasibility and effectiveness of quality assurance and monitoring 
mechanisms. Several have been piloted over the past two decades, but with little systematic 
documentation or evaluation. Key issues concerning standardized indicators, data-collection systems, 
and feedback and data utilization mechanisms remain under-researched. Quality monitoring and 
assurance feature prominently in FP2020, particularly within the Monitoring and Accountability 
Working Group. It is hoped that this will encourage investment in generating evidence regarding how 
such mechanisms can be standardized and can function effectively and efficiently.  
Increasing engagement of the commercial sector in providing FP through private clinics is particularly 
noticeable through the burgeoning of social franchising. Recent reviews (Madhavan and Bishai 2010; 
Mwaikambo et al. 2011; Stephenson et al. 2004) find strong evidence that franchising does increase 
access to and use of FP services, moderate evidence of improved quality, and moderate evidence of 
increased use by the poor. The extent to which franchising addresses equity is, however, uncertain. Only 
one study has addressed cost-effectiveness, but it was inconclusive. Given the potential of this approach, 
further research is justified regarding its effect on quality of care and equity as well as its relative cost-
effectiveness.  
Integrating FP with other services. Increasing emphasis is being placed on integrating FP into other health 
services, acknowledging both that women’s RH needs are often multiple and that a visit to a clinic 
represents a valuable and perhaps rare opportunity to address a woman’s FP needs. The evidence base 
concerning the feasibility, acceptability, effectiveness, and cost-effectiveness of integrating FP into 
various maternal, infant, and child health services is extensive, yet awareness of this evidence and its 
routine use in programming, especially for postpartum FP services, remains remarkably limited. Recent 
reviews usefully summarize the evidence (Hiller, Griffith and Jenner 2007; MCHIP 2012; Vernon 2009) 
and provide programmatic recommendations for which models of integration with maternal, newborn, 
and child health services have been demonstrated to be effective and thus should be scaled-up. There 
appear to be few major evidence gaps. Some issues that would benefit from further evidence are: how 
best to link FP counseling during antenatal care (ANC) with postpartum use; how to involve male 
partners; whether tubal ligations can be offered safely and with informed choice following caesarean 
sections; whether child immunization visits are a cost-effective opportunity; and method preferences 
among postpartum women living with HIV (MCHIP 2012). Women at 12 months postpartum have 
extremely high levels of unmet need (near 65%); thus, investing in scaling up evidence-based postpartum 
FP strategies should be a priority for FP2020.  
For almost two decades, postabortion care (PAC) has explicitly incorporated counseling and, if desired, 
delivery of FP. When FP is routinely offered to PAC clients, the evidence is unequivocal that clients are 
more likely to receive a contraceptive method than when it is not (USAID 2012c) and so is considered 
a proven best practice. The one study to evaluate longer-term outcomes found that exposure to 
postabortion FP resulted in significantly fewer abortions and unintended pregnancies during the 12-
month follow-up period (Johnson et al. 2002; USAID 2012c). No study exists, however, on the impact 
on maternal mortality and morbidity of providing postabortion FP (Tripney et al. 2011; Tripney, Kwan 
and Bird In press).  
In most developing countries, post-rape care is still a nascent RH service, although growing 
recognition of the scale and severity of sexual assault means greater investment in piloting country-
specific models and preparing for scale-up. Emergency contraception (EC) is an integral component of 
any post-rape care model, as 5-18% of rapes result in a pregnancy. Evidence currently available is 
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limited to documenting the feasibility of offering EC within a comprehensive package of services 
(Keesbury and Thompson 2010). No evidence exists of its effectiveness in reducing pregnancy 
following rape.  
The rationale for integrating FP with HIV services is well-established, both through offering FP within 
HIV services and HIV services within FP services (Wilcher, Cates and Gregson 2009). Moreover, 
evidence concerning the feasibility of various models of integration is sufficiently strong to support 
investment in piloting and scaling up (Church and Mayhew 2009; Spaulding, Brickley and Kennedy 
2009). The evidence base describing which models work more effectively, efficiently, and equitably is still 
modest, and is characterized by generally low levels of scientific rigor. However, recent significant 
investments in rigorous evaluations of integrated models that measure their association with unintended 
pregnancies, HIV/STI incidence and stigma, as well as comparisons of outcomes between linked 
services with stand-alone services, will yield substantial improvements in the quantity and quality of the 
evidence base over the next couple of years.  
Moreover, from an HIV-prevention perspective, evidence from modeling demonstrates that reducing 
unmet need for FP, and consequently unintended pregnancies, in a population with high HIV 
prevalence (with or without women knowing their status) has a significant impact on reducing perinatal 
HIV transmission (Reynolds et al. 2008). A recent review of the evidence by a WHO expert group 
found conflicting evidence regarding whether women using progestin-only injectable contraceptives 
may be at increased risk of HIV acquisition. The review recommended that women using progestin-
only injectable contraceptives be strongly advised to also use condoms and other preventive measures 
(WHO 2012a).  
Community-based. Community-based distribution (CBD) of FP has been an important strategy in all 
regions of the world for more than three decades. A vast body of documented experience, together with 
research-based evidence from numerous evaluations with varying levels of rigor, has demonstrated the 
acceptability, effectiveness (in generating demand and increasing access and use), and cost-effectiveness 
of CBD agents, as well as providing programmatic guidance for implementation (Mwaikambo et al. 2011; 
Phillips, Greene and Jackson 1999).  
With the realization that providing FP through multipurpose CHWs is more efficient and better meets 
women’s needs than through CBD agents, attention has shifted to identifying the evidence concerning 
CHWs as a source of FP information and services. A recent review (USAID 2012a) using evidence with 
varying levels of rigor showed that: (a) CHWs can meet the immediate and growing need for human 
resources where services are most needed; (b) CHWs can help reduce inequities in FP use and 
particularly for women with constrained mobility; and (c) CHWs can safely and effectively provide a 
wide range of methods, including pills, condoms, injectables, Standard Days Method (SDM), lactational 
amenorrhea method (LAM), and EC. Preliminary evidence also indicates that under appropriate 
conditions, CHWs can provide implants and intrauterine devices (IUDs). Further evidence is needed 
concerning the safety and impact of CHWs providing these long-acting methods. Evidence gaps also 
remain concerning the role of CHWs in meeting the needs of unmarried adolescents, recently married 
girls, males, and urban slum populations; the relative cost-effectiveness of CHWs compared with clinic-
based and mobile outreach models; and the feasibility and effectiveness of outreach workers in other 
sectors (e.g., agriculture, development) as FP providers.  
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Mobile outreach. Provision of long-acting contraceptive methods by a mobile team of trained providers, in 
a modified vehicle or in a temporary facility or camp, has been a strategy used for many years but with 
little research-based evidence to describe performance or effectiveness. A recent review of the existing 
evidence (USAID 2012b) indicates that, in many settings, mobile outreach can: (a) supply between one-
fifth and more than one-half of all users of particular methods; (b) outperform fixed facilities and at a 
lower cost; (c) reduce some inequities by reaching some underserved populations, especially those living 
in remote locations; and (d) reach women who have never previously used any FP. The evidence base 
remains limited, however, regarding issues such as women’s health-seeking behaviors for complications, 
switching or discontinuation, client satisfaction, overall quality of service, reaching vulnerable 
populations living in remote locations, and the cost-effectiveness of mobile outreach.  
Social marketing and pharmacies. Using commercial-marketing techniques to promote socially beneficial 
behaviors and make available subsidized FP commodities and services through commercial outlets is an 
increasingly popular service delivery model, particularly for delivering short-acting methods such as pills 
(including EC), condoms, SDM (cycle beads) and injectables. A recent review (Madhavan and Bishai 
2010) found moderate evidence that social marketing increases access to FP products and messages, 
though their effect on inequities was not measured. Strong evidence was found of the cost effectiveness 
of social marketing, and moderate evidence that increasing price reduces use. One review (Chapman and 
Astatke 2003) found that the socioeconomic status of women served through social marketing tends to 
be lower than women purchasing commercial brands and higher than those who obtain their products 
from the public sector.  
Although pharmacies often participate in social marketing programs, little evidence exists regarding the 
role that pharmacies and drug shops can play when specific interventions are introduced to strengthen 
their capacity to offer FP services. A recent review (Solo and Malarcher 2012) summarizes the limited 
evidence of their ability to safely provide many methods, and their potential to reach urban poor 
populations, including unmarried adolescents and males who may be stigmatized when visiting clinics. 
It also notes that rigorous evidence is lacking on these issues as well as on quality of care and the cost-
effectiveness of the approach.  
Married and unmarried adolescents. Many interventions have been developed to reduce health systems 
barriers for adolescents, but few have been rigorously evaluated. A recent systematic review (WHO 2011, 
2012c) found little evidence, and the evidence that does exist is generally fairly weak. As a result, several 
research recommendations were made: (a) identify feasible and effective interventions that result in the 
formulation of laws and policies that reduce barriers to adolescents accessing contraceptives; (b) identify 
and evaluate interventions that influence community members’ support for access to contraceptives 
among adolescents; (c) identify feasible and effective interventions to improve the availability of over-
the-counter hormonal contraceptives to adolescents; (d) determine the effectiveness of interventions that 
provide accurate information and education about contraceptives in various settings and populations 
(both in-school and out-of-school); (e) identify feasible and effective interventions that involve 
adolescent and adult males in decisions concerning contraceptive use by partners and by themselves, 
including interventions that aim to transform gender norms; (f) determine the feasibility, sustainability, 
and impact of reducing the cost of contraceptives for adolescents.  
The majority of sexually active adolescent girls in developing countries are married (Haberland 2003), yet 
health system-based interventions to address the FP needs of married adolescents are relatively new, and 
generally seek to reach and support married adolescent girls and their husbands and families with 
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targeted activities and services. Few rigorous evaluations have been undertaken but a number of 
promising practices are emerging from studies using quasi-experimental designs. Such studies feature 
combined community, couple, and individual SBCC strategies to build a supportive social environment, 
and education-and home-based supply of FP, especially during the postpartum period following the first 
birth (DFID 2010a).  
Other vulnerable populations. The evidence base regarding the particularities of delivering FP services to 
urban slum dwellers, and especially to young people, is growing with recent substantial investments in 
urban-focused FP programs and an independent, complementary evaluation project. More evidence will 
be needed as the number and range of urban-focused interventions expands rapidly through FP2020; in 
particular, evidence of such interventions to reduce inequities within urban populations, especially young 
and unmarried populations. The private sector is likely to feature prominently as a source of 
commodities, and the electronic media, especially mobile phones, as a source of information. As urban 
slum populations continue to grow exponentially and with young populations, the importance of 
generating a rigorous evidence base to guide programming for meeting the needs of the urban youth 
living in poverty cannot be exaggerated.  
As noted above, the evidence base for interventions that meet the FP needs of women living with HIV 
is growing rapidly through both research and experience. With an initial focus on integrating FP 
services into prevention of mother-to-child transmission (PMTCT) and ART services for HIV-positive 
women in high prevalence settings, there are increasing efforts to determine the client’s HIV status 
during FP, ANC, and postpartum services so that the consultation can be tailored to meet their needs 
during a routine consultation rather than through stand-alone HIV services. Evidence for how this 
expanded service can best be done is still emerging.  
Unintended pregnancy and use of contraceptives among sex workers is poorly understood. No 
systematic review of this sparse literature has been conducted. Such a review would be helpful because 
the evidence available is unclear regarding whether sex workers have higher or lower levels of unmet 
need than the general population. Nomadic and migratory populations, although relatively small in 
number, are highly vulnerable and their needs can be acute. No evidence exists concerning service 
delivery or models for reaching them, however.  
Human Resources 
Many cadres of health workers have been trained to provide FP information, counseling, and services. 
Task shifting and sharing are currently being promoted as a strategy for expanding access to FP through 
enabling larger numbers of health workers to offer a wider range of methods. A recent review of the task 
sharing evidence (WHO 2012b) produced recommendations for which cadre could safely and effectively 
provide which types of contraceptive method. This review also identified some evidence gaps that need 
to be addressed through rigorous research so that a determination can be made concerning whether the 
following cadres can provide the following contraceptives: (a) trained Lay Health Workers and 
Traditional Birth Attendants (TBAs) providing implants; (b) auxiliary nurses providing IUDs and 
vasectomy; (c) auxiliary nurse midwives providing vasectomy; and (d) nurses and midwives providing 
tubal ligation and vasectomy. It also recommends two situations in which cadres should provide 
methods although with targeted monitoring and evaluation (M&E): i) Lay Health Workers and TBAs 
providing injectables; and ii) auxiliary nurses and auxiliary nurse midwives providing implants. 
Additionally, the review recommended that, for services for which the evidence does support task 
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shifting or sharing without further research—namely, auxiliary nurses and auxiliary nurse-midwives 
providing injectables, and nurses and nurse-midwives providing implants—national programs should be 
provided with technical assistance to rapidly amend policies and programs to scale up the evidence-based 
best practices.  
As health systems expand their capacity to offer FP services, a focus on task sharing should not divert 
attention from broader human resource concerns that can prevent health systems from functioning at 
full potential (DFID 2010b). Staff shortages, their distribution and rotation, skills competency, lack of 
supervision, and other human resource issues, are frequently cited as barriers during implementation of 
new FP interventions. Localized evidence is needed to identify solutions to these problems that can be 
generated primarily through health systems research methods such as training audits, competency 
assessments, case studies, health facility assessments, and policy analysis.  
A second area in which evidence is needed urgently is the role of electronic and mobile information and 
communication technology for training, monitoring, and supervising health workers. Despite the great 
interest in and potential for these technologies to improve provider competence and system efficiency, 
no rigorous evidence of feasibility, acceptability, effectiveness, and cost-effectiveness exists. Great care is 
needed, therefore, to ensure that large-scale ehealth/mhealth interventions are not rolled out without 
sufficient evidence to determine how their introduction will impact the health system.  
Systems Information 
Effective and efficient delivery of FP services requires the production, analysis, and communication of 
data regarding the performance of service delivery sites and providers, and the relation between use of 
FP services and achievement of reproductive intentions through prevention of unintended pregnancy. 
Performance monitoring will be critical if the FP2020 goals are to be achieved. The collection, 
processing and use of performance-related data is usually organized through the design and 
implementation of an M&E strategy. M&E strategies are informed primarily through experiential rather 
than research-based evidence and usually conceptualized according to logical frameworks based on a 
“theory of change.” At the heart of most M&E strategies for FP service delivery is a health management 
information system (HMIS) that records and reports the delivery of FP services.  
Most national HMISs are notoriously weak at monitoring FP performance. Incorporating data from the 
non-public sector into an HMIS has proved difficult. Because HMISs also do not usually track client 
characteristics, monitoring whether inequities are being reduced will be difficult without changes. 
Because they also do not regularly monitor quality of care, sufficient investments will be needed to 
strengthen and amend national HMISs and link them with the evolving global framework being 
developed by the FP2020 Performance Monitoring and Accountability Working Group. Moreover, if 
an accountability mechanism is to be established and function so that it can routinely track that service 
delivery is rights-based, it will need to be linked directly with the national HMIS.  
Although the overall goal of FP2020, 120 million new users, can be tracked through a strengthened 
HMIS, the population-level impacts of the various interventions implemented to meet this goal will also 
need to be measured through data generated through representatively sampled surveys. Historically, the 
DHS mechanism has provided these data, but with the increased focus on unmet need, unintended 
pregnancy, and equitable access—all measures that require population-level samples—there is likely to 
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be a need for increased investment in surveys, including in the human resources to undertake them, 
analyze the findings, and support the uptake of this evidence by stakeholders and decision-makers.  
Paper-based HMISs are increasingly being replaced by electronic systems, handheld devices for data 
collection and transmission, and computerized analyses are informing budgeting and planning 
decisions. Despite their rapid increase, rigorously tested and validated electronic HMISs that can be 
used with ease by program and clinic managers are still a minority. Substantial investment in 
computerization of national HMISs and in building human resource capacity to use them effectively 
should be a priority as FP2020 rolls out at the country level.  
Commodities 
Maximizing global access to FP commodities in accordance with quality assurance requirements at 
affordable and sustainable prices, or “market shaping,” is one of the objectives of FP2020. Problems 
with FP commodity production, pricing, forecasting procurement needs, efficient supply logistics, and 
quality assurance have all been identified as key barriers that restrict access and choice for women 
wishing to use FP, thereby contributing to unmet need. To plan for and implement a market-shaping 
strategy that will reduce these barriers to develop a more efficient, effective, and equitable market for 
FP commodities will require substantially more evidence than is currently available. For example, the 
FP2020 Market Dynamics Working Group is expected to improve processes and tools for demand 
forecasting, coordinated procurement, harnessing innovative financing, strengthening supply chains, 
and testing innovative products. All of these processes and tools will require valid, regular data, some of 
which can be generated through an HMIS, but most will need to be documented and analyzed through 
new procedures and mechanisms.  
In particular, validated TM approaches will be needed to assess the characteristics of existing and likely 
future markets, and to define the comparative advantage of commercial, social marketing, non-
governmental organization (NGO), and public sector actors in terms of their competence and value for 
money in delivering a range of products or services to different market segments, including the poorest. 
Rigorous methods for defining, measuring, and monitoring method mix, both in terms of demand and 
supply, will be essential for maximizing choice. Evidence to support the bridging from product 
development to market introduction is lacking. Conceptual frameworks and critical pathways exist, but 
with limited validation and demonstration of utility across the spectrum of methods.  
Some specific evidence gaps exist for the provision of individual contraceptive commodities:  
 
 Condoms: Male condom use is increasing rapidly among unmarried people, especially in Africa. 
Evidence is needed regarding how to sustain its use after marriage, especially as a dual protection 
strategy. Evidence concerning programming for female condoms (FC) is increasing slowly; until 
recently there has been limited interest in FC as a family planning method per se among potential 
users and providers. Provider and policy bias has inhibited investment in research and programming, 
although that has begun to change with the recent development of newer models of female condoms 
coming on the market. 
 Contraceptive vaginal rings (CVR): Extensive research is needed regarding how best to introduce 
and mainstream both progesterone-only and other CVRs. For the latter, market forecasting for 
developing countries and evidence are needed to inform strategies for affordable production, 
procurement, and sales.  
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 Emergency Contraception (EC): Although evidence-based guidance concerning the introduction 
and mainstreaming of EC products does exist (Hossain and et al. 2009), the UN Commission on 
Life-Saving Commodities for Women and Children has included EC (together with implants and 
FCs) in its list of over-looked commodities. Earmarked investments will become available to expand 
the evidence base regarding the supply of this commodity.  
 Injectables: This is the most rapidly increasing contraceptive commodity being used in Africa. 
The implications of this rapid increase in access and use need better understanding, especially in 
countries with high HIV prevalence for which concerns remain about its possible association 
with HIV acquisition. Conversely, use of injectables in South Asia is relatively limited, and more 
evidence is needed to determine whether there is greater potential demand and if so, how this 
could best be met.  
 Implants: Evidence concerning implants is fairly complete, with the main gap being the extent to 
which provision of this method can be task shifted to lower-level cadres to increase access, 
especially in rural areas. Evidence concerning their use by adolescents is limited.  
 IUD/intrauterine system: The evidence regarding reasons for non-use is generally quite good. 
The main evidence gap is the extent to which method provision can be task shifted to lower-level 
cadres to increase access, especially in rural areas.  
 LAM: Evidence is still needed regarding how best to facilitate the transition from LAM to an  
effective contraceptive technology after breastfeeding.  
 Oral contraceptive pills: No further evidence seems to be needed at this point in time.  
 SDM: Evidence suggests that demand exists for SDM and that this can increase as availability 
and awareness increase. The method is most popular among women not currently using an 
effective method, thus providing programs a strategy to reach underserved couples; how best to 
do this needs informing through locally obtained evidence (Lundgren 2012).  
 Tubal ligation: Options for easier procedures are currently being explored and evidence is needed 
to determine the extent to which lower cadres can task share its provision.  
 Vasectomy: Evidence is needed concerning the reasons for non-use and to identify innovative 
and effective ways to communicate messages, especially in Africa.  
 What is next? Emerging contraceptive and multipurpose prevention technologies (MPTs): A 
diverse set of research endeavors will be needed as new technologies enter into clinical trials and 
pre-introduction studies.  
 
Financing 
Increased effectiveness and efficiency in health systems functioning is intimately tied to the way in which 
systems are financed. Most public sector and NGO health programs pay for the inputs needed to 
produce FP services and not for their performance outputs or outcomes (i.e., whether FP services are 
actually delivered or whether the population’s RH improves). Paying for performance (P4P), result-based 
financing (RBF), output-based aid (OBA), performance-based financing (PBF) performance-based 
incentives (PBI), and other similar terms describe interventions that finance a health system through 
paying for the outcomes delivered. Over the past decade, many models have been and continue to be 
developed and tested using this principle, and indeed some major donors are also configuring their 
service delivery tenders so that payment is performance-based.  
As described by a recent Cochrane review, the evidence base for PBF is presently too weak to draw 
general conclusions. PBF is not a uniform intervention; its impact depends on the interaction of several 
variables, including the design of the intervention (e.g., who receives payments, the magnitude of the 
14 
incentives, the targets and how they are measured), the amount of additional funding, other ancillary 
components such as technical support, and contextual factors including the organizational context in 
which it is implemented (Witter et al. 2012). For maternal health, an “evidence summit” convened in 
mid-2012 provided the focus for collating and synthesizing the evidence concerning the full range of 
financing mechanisms being piloted. The evidence summarized at that meeting is currently being 
prepared for distribution and should be available by early 2013.  
For FP specifically, several PBF mechanisms are being tried (Eichler et al. 2010): donors incorporating 
PBF in the way they structure payment to countries by conditioning aid on evidence of health results; 
national governments transferring funds to sub-national levels of government based partly on attainment 
of health or coverage targets; donors paying NGOs for results that include FP; rewarding health facilities 
for quality counseling and availability and use of modern FP methods; reducing financial barriers to 
accessing FP by selling to poor women vouchers for FP services at subsidized rates from accredited 
providers; and conditional cash transfer (CCT) programs providing income support to poor families if 
they meet health and education conditions that include participating in health education talks about FP 
and some evidence of increased FP use (Mwaikambo et al. 2011). Given the high level of interest in PBF, 
further investment in research concerning these various PBF mechanisms is critical. In particular, 
concerns regarding the potential for coercion when incentives are used with FP providers need to be 
carefully addressed in any research (Eichler et al. 2010). In addition, the effect of PBF programming on 
equity also needs to addressed, because the evidence available appears mixed (Hotchkiss 2011; 
Ravindram and Fonn 2011). Moreover, the relative cost-effectiveness of alternative PBF models is an 
important policy issue for which there is no firm evidence.  
Many national governments have made substantial commitments to FP2020. It is likely, therefore, that 
traditional “input-based” financing for FP services through allocations from the countries’ finance 
ministries is likely to continue to be the predominant model in the public sector. Evidence is needed, 
therefore, regarding how existing governmental financing mechanisms function and can be improved—
for example, through country-specific and meta analyses of national health accounts and other resource 
tracking methods.  
The influence of price on the acceptability and use of different contraceptive methods is not clear. 
Definitive evidence regarding the price elasticity of contraceptive demand is still scarce, and much 
evidence tends to come from observational studies from the 1980s and 1990s. Most evidence indicates 
that contraceptive pricing is actually quite inelastic (Cleland et al. 2006), although income seems to be a 
factor in determining elasticity, implying that the poorest are more likely to be affected by user fees 
(DFID 2010a). More up-to-date rigorously designed studies are needed concerning the impact of user 
fees or out-of-pocket payments on contraceptive use and RH and potential equity impacts (DFID 
2010a).  
Leadership and Governance 
The importance of political commitment as a determinant of demand for and use of FP cannot be 
overstated. Indeed, increasing such commitment is one of FP2020’s four objectives. Trends in global and 
national support for FP are associated with trends in demand for and use of FP (Cleland et al. 2006; 
DFID 2010b). The stall in fertility decline in sub-Saharan Africa can be attributed in large part to 
ambiguous national will and reduced global commitment to FP throughout the 1990s and early 2000s 
(Bongaarts et al. 2012; Cleland et al. 2006), and recent rapid increases in FP use in several African 
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countries can be attributed to increased political will (Murunga et al. 2012; USAID Africa Bureau 2012). 
Evidence supports the role of political commitment for increasing awareness of and demand for FP, as 
well as enhancing investments in and effective implementation of service delivery strategies to reduce 
unmet need (Jacobstein et al. 2013; Lee et al. 1998). Following the political and financial commitments 
made at the London FP Summit in July 2012, substantial investments will be made in advocacy efforts 
over the next few years to capitalize on these commitments. However, little evidence currently exists to 
guide investments in advocacy, to ensure that they are effective in increasing access, reducing unmet 
need, and addressing inequities. In addition to evaluations of recent and on-going advocacy initiatives 
(Murunga et al. 2012; USAID Africa Bureau 2012), prospective research is needed to evaluate the 
feasibility, implementation process, and effectiveness of forthcoming advocacy projects.  
To ensure that these commitments translate into investments in a rights-based approach to reducing 
unmet need, FP2020 will be supporting mechanisms that hold governments, donors, and other 
organizations making and implementing the commitments accountable to the intended beneficiaries. 
Within the FP2020 architecture, both the Rights and Empowerment and Performance Monitoring and 
Accountability Working Groups will be responsible for ensuring accountability. They will require 
rigorous evidence to guide them in empowering communities, especially the most marginalized, to voice 
their needs and demand their entitlements, engage in decision-making to design and implement service 
delivery; and monitor potential rights abuses concerning FP provision. Accountability mechanisms do 
exist for FP, but evidence of their feasibility and effectiveness is limited primarily to case studies 
(Bongaarts et al. 2012; DFID 2010b; DFID 2010a). In anticipation of a rapid increase in accountability 
mechanisms, operations research to develop, test, and evaluate accountability interventions should be an 
urgent priority.  
Demand and Use Dynamics  
A thorough and context-specific understanding of the demand and use dynamics for FP is critical for 
planning to expand access to and reduce unmet need for FP through FP2020. Moreover, to ensure that 
all responses are rights-based and will contribute to universal access through reducing inequities, all 
analyses must disaggregate population-level data by the relevant social determinants for each country. 
The DHS provides substantial datasets from which many analyses of demand and use dynamics have 
been, and can be, undertaken. Given the scale of investment and the need to target interventions 
strategically for diverse populations, undertaking additional population-specific DHS-like surveys will 
probably be necessary to determine the specifics of such dynamics, especially for particularly vulnerable 
and poorly-documented populations.  
 
In determining why many women with a demand for FP have an unmet need, understanding the 
reasons for non-use is an essential starting point. Unfortunately, the evidence base for understanding 
the reasons for non-use is still limited, due in part to an over-reliance on the evidence generated 
through the “reasons for non-use” questions used in the DHS. While useful if carefully interpreted, 
there is an urgent need for additional standardized measures that are able to describe the ambivalence 
women often feel concerning contraceptive use, their perceptions of various risks associated with use 
or non-use, and that can capture changes over time. Moreover, more nuanced and insightful 
interpretations of the responses given and their implications for investments in programming are 
needed. For example, in most developing countries, lack of access or high cost are no longer the 
primary reasons for non-use – infrequent sex and fear of side effects are the most commonly cited – 
(Darroch et al. 2011), possibly because most investments in FP programming over the past two decades 
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have been oriented towards reducing these barriers, and with apparent success. Future investment 
should be determined by the key reasons, disaggregated by population groups, within each country.  
Recent evidence highlights the importance of and reasons for discontinuation, switching, and failure as 
factors determining unintended pregnancy and achievement of reproductive intentions (Ali, Cleland and 
Shah 2012). Indeed, one-third of unintended pregnancies occur among women who are using FP (i.e., 
have a met need). Better addressing the needs of women already using FP may be as effective a means of 
reducing unintended pregnancy as focusing on new users (Jain 1989). High rates of discontinuation (on 
average, around 40% at 12 months) stress the need to both ensure access to longer-acting effective 
methods, as well as improve service quality, particularly counseling, so that women can make an 
informed choice and are forewarned about side-effects and reassured about health concerns. Timely and 
informed method-switching needs to be better recognized to avoid unintended pregnancies, abortion, 
and unwanted or mistimed births. A lack of longitudinal data, especially prospectively collected, hinders 
better understanding of these important use dynamics.  
One weakness of the DHS is that it does not adequately sample for adolescents and other non-married 
women, women living in vulnerable situations (e.g., sex workers, women living with HIV) and men. 
Although varying by country, these populations can suffer a significant proportion of the unmet need. 
Thus, more evidence is essential to understand contraceptive demand and use dynamics among these 
populations, either through strengthening the DHS or undertaking further population-specific surveys. 
For example, several countries have recently commissioned surveys of young people.  
Determining whether a woman is using a method that is appropriate for her needs at a particular point in 
her life cycle, and whether there may be other, more suitable methods that are not available to her, is an 
important element of use dynamics that influences choice. It can also affect the likelihood of unintended 
pregnancy if she is using a less effective method because more effective options are not available, 
accessible, affordable, or acceptable. And it can potentially affect the cost of using and of providing 
contraceptives. Longer-acting methods generally cost less per couple year of protection (cost is 
amortized over longer term), than short-acting methods, and so a lack of access to such methods can 
increase costs to the woman and to the program. Information regarding the appropriateness of a method 
for a woman’s reproductive intentions is critical for any market-shaping initiatives; thus, investments in 
generating such evidence would be extremely helpful.  
 
Associations between FP Use, Non-Use, and Distal Outcomes  
A central goal of family planning is to enable women to space and limit their children according to their 
own needs and desires. Family planning provides the means through which a woman’s right to have 
children by choice and not by chance can be actualized. In addition, FP has important social, economic, 
environmental, and population implications. The associations between FP use and fertility, maternal, 
infant, and child health, population dynamics, economic development, poverty reduction, and food 
security are well-established after decades of research (Bongaarts et al. 2012; Bongaarts and Sinding 
2011). This evidence is used primarily to advocate for political and financial commitment, which has 
proved essential in refocusing global and national attention on the adverse outcomes associated with 
unintended pregnancy and unwanted fertility. This evidence is also used for development planning by 
countries with emerging economies, as the integral role of population health and dynamics in poverty 
reduction and a country’s economic and social growth is increasingly grasped by politicians and 
economists.  
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Going forward, a continued investment in the generation and interpretation of demographic evidence 
remains critically important, especially in countries where the fertility transition is not yet complete and 
where important fluctuations in these relationships must be monitored. Moreover, in countries that 
could potentially benefit from a “demographic dividend” – when the working age population is 
increasing faster than the dependent population, leading to rapid economic growth (Cleland 2012) – 
country-specific analyses that inform policymakers and politicians of how this dividend can be achieved 
would be important advocacy interventions and should be supported. A recent review of the likelihood 
of a demographic dividend in Africa cautions against expecting the same scale of dividend as those 
witnessed in East and South Asia unless the institutional setting is favorable, the economy is able to 
generate employment and provide education and health care for the increasing labor force, and 
household savings can lead to productive investments (Cleland 2012). Without these associated factors, 
rapidly increasing numbers of unemployed, poorly educated young people can lead to discontent and 
strife.  
As the number of women in the reproductive age group increases because of population growth, so 
does the number of women needing contraceptive services and commodities. Thus for many 
developing countries seeking to increase access to FP, an important outcome is that the number of 
commodities required will increase dramatically due to the combination of increasing contraceptive 
prevalence and increasing population size; for example, between 2008 and 2012, an additional 42 
million women were using contraceptives, half of which was due to population growth (Singh and 
Darroch 2012).  
More recently, research on the associations between FP use, population growth (especially in urban 
populations and those living on coastal and desert fringes), the environment, and climate has become 
increasingly prominent and will continue to do so (Jiang and Hardee 2011). Although links between 
global climate patterns and a woman’s right and means of having children by choice and not by chance 
may seem too distant to many, evidence from such analyses will become increasingly important for 
policy discussions and investment choices, especially in countries suffering from environmental 
degradation and problems meeting the food, water, and sanitation needs of their populations.  
Using Research, Monitoring, and Evaluation for Guidance Development  
The scientific evidence that informed this review draws from data collected through numerous 
methodologies and from a variety of sources. Broadly speaking, these can be categorized into: a) 
Research studies using social science methods to collect and analyze quantitative or qualitative data 
using designs that seek to maximize the validity and reliability of the findings (including, for example, 
the DHS); b) Formal evaluations of the feasibility, acceptability, cost, and effectiveness of service 
delivery and system strengthening interventions that seek to increase access to and use of FP; c) 
HMISs that routinely monitor systems performance in delivering FP information and services.  
Much of the focus in this review has been on research to improve health systems. The past decade has 
seen a burgeoning of research strategies, approaches and methods being applied to generate evidence to 
influence decisions around health systems strengthening; indeed, global conferences on health systems 
research held in 2010 and 2012 attest to the sheer scale of research being undertaken. An unfortunate 
consequence has been the plethora of definitions and terms that have been developed and applied to 
this research, resulting in confusion and misunderstandings, not least among research donors and 
researchers themselves. A review and framing of the key domains (operational, implementation, health 
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systems) that comprise research to improve health systems (Remme et al. 2010) provides a useful 
starting point from which research donors and researchers can understand and agree upon definitions 
and categories of research for framing and organizing future research investments.  
Evidence for informing strategic investments to increase access to FP derives primarily from formal 
evaluations of intervention feasibility and effectiveness, although those responsible for making such 
investment decisions are increasingly seeking evidence of an intervention’s impact on quality of care, on 
universal access and equity, and on its sustainability. Evidence of effectiveness is usually considered to be 
of highest quality, and so can provide the strongest recommendations for action, if it is derived from a 
randomized controlled trial (RCT). As this review found, RCTs are rarely undertaken in FP research for 
numerous reasons: they may be too costly; they may not be ethically or practically feasible; or they may 
produce evidence that is not programmatically useful. While recognizing the theoretical strength of these 
“probability” designs, the role of “plausibility” designs in generating evidence that is of acceptable quality 
to decision-makers and can be used to make strong recommendations is gaining acceptance (Bosch-
Capblanch and Team 2011; Victora, Habicht and Bryce 2004). Such designs are often quasi-experimental 
and use multiple methods and sources to generate data that provides a plausible, rather than statistically 
probable, attribution of effect to the intervention 
being evaluated.  
Recommendations for expanding access to FP that 
derive from research-based evidence are frequently 
framed as service delivery ‘guidelines’ or systems 
strengthening ‘guidance’, defined in a WHO-
commissioned handbook as “the systematically 
developed body of knowledge, integrating research 
evidence and descriptions of the types of other 
considerations needed to inform decision making 
about appropriate health system arrangements in 
specific settings” (Bosch-Capblanch 2011); The 
handbook proposes a rigorous and systematic process 
for reviewing and using research-based evidence for 
health systems guidance and policymaking (Bosch-
Capblanch et al. 2012; Lavis et al. 2012; Lewin et al. 
2012).  
What qualifies as high quality “evidence” and what is a 
“best” or “proven” implementation practice remains 
open to debate, however. Other approaches to 
reviewing and synthesizing evidence and formulating 
guidance have accepted evidence from non-RTC 
designs and more experiential evidence, for example 
DFID’s series of “evidence reviews” on Reproductive, 
Maternal and Newborn Health, and USAID’s “High 
Impact Practices in Family Planning (HIPs)”. Lack of 
agreement on the criteria for evidence quality and its 
use in the formulation of policy and programmatic 
recommendations, especially at the global level, will 
Evidence Gaps: Areas for  
Research Investment 
Approaches to Determining Inequities and Identifying 
Needs of Underserved and Vulnerable Populations  
Methodologies to Prospectively Evaluate Structural 
Interventions to Reduce Inequities and Vulnerability  
Interventions to Meet the Needs of Unmarried and 
Married Adolescents  
Interventions to Improve and Sustain the Quality of 
FP Services  
Strategies for Scaling up Effective Models of 
Integrated Services  
Strategies for Reaching Rural Communities  
Strategies for Reaching Urban Poor Populations  
Techniques for Defining and Shaping Contraceptive 
Markets to Improve Availability and Access  
Innovative Financing Mechanisms to Expand Access 
and Increase Affordability  
Strategies for Advocacy and Accountability  
Understanding the Dynamics of Contraceptive 
Decision-Making and Use  
Building Capacity and Improving Methods to 
Generate and Use Evidence on FP  
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inhibit FP2020’s ability to introduce and expand effective interventions for reducing unmet need; 
achieving such consensus is an urgent priority.  
Research Gaps  
This review shows that a substantial body of evidence concerning the determinants, outcomes and 
dynamics of contraceptive use and unmet need has been, and continues to be, generated through a 
range of research and evaluation activities. Prior investments over several decades in research and 
evaluation, including building capacity to produce and use research-based evidence, has yielded an 
impressive body of knowledge that has guided the development and expansion of FP information and 
services in many developing countries.  
The commitments made at the London FP Summit, and the establishment of the FP2020 initiative to 
implement these, require that many developing countries will need to rapidly and efficiently increase the 
scale and intensity of existing FP delivery systems, while simultaneously expanding the number and 
diversity of public and non-public sector markets through which FP can be accessed by those needing 
FP services. The evidence base to guide how best to do this is, however, lacking in several key areas, as 
described above. The following evidence gaps warrant consideration for immediate investment in 
research and in building research capacity.  
 
Approaches to Determining Inequities and Identifying Needs of Underserved and 
Vulnerable Populations  
Although the social determinants of FP demand and use are well understood, how these function in 
specific national and sub-national contexts must to be clearly mapped if countries are to implement 
rights-based approaches to reducing unmet need. For many countries, population-level surveys, in 
addition to or as a component of a regular DHS, that are designed to more precisely determine inequities 
in access to and use of FP are needed urgently to inform programming, policy and, importantly, 
budgetary allocations and investments within a country’s FP2020 plan. Using these surveys as a baseline, 
they should be repeated regularly to detect and monitor whether reductions in inequities are occurring 
and whether underserved and vulnerable populations are being reached.  
 
Such research should proactively engage those often excluded in routine surveys, such as married and 
unmarried girls and boys, sex workers, migrants, and indigenous and slum populations. In-depth analyses 
should also be conducted to determine the specific needs of vulnerable and underserved populations and 
to identify targeted interventions that would increase their access and empower them to hold the health 
system accountable. This evidence would also provide countries the opportunity to provide “voice” to its 
vulnerable groups so that they can actively engage in FP programming.  
 
Methodologies to Prospectively Evaluate Structural Interventions to Reduce Inequities and 
Vulnerability  
The importance of structural determinants in limiting access and use of FP is well-understood; much 
more evidence is needed, however, of the feasibility and effectiveness of interventions that can reduce 
the inequities and vulnerabilities that they cause. Evidence of the effectiveness of interventions that 
reduce early marriage, reduce unmarried girls’ exposure to unwanted and coerced sex, and empower 
women to meet their reproductive intentions is largely non-existent. Evidence is also needed concerning 
“gendered” interventions that enable more positive and balanced interactions by girls and women with 
their partners, families, and communities. Prospective, rigorously designed impact evaluations of multi-
20 
faceted structural interventions are needed. Although requiring substantial investments of time and 
funding, they would generate evidence that would not only increase FP use but also improve social 
relations, gender dynamics, and women’s and girls’ rights more widely.  
 
Interventions to Meet the Needs of Unmarried and Married Adolescents  
Adolescent girls and boys, both married and unmarried, form substantial proportions of those with 
unmet need; moreover, they are often among the most vulnerable and underserved of populations and 
their needs for appropriate sexuality education are often as great as their need for contraceptives. 
However, despite the evidence generated through many and varied initiatives over the past two decades, 
context-specific research is critical if countries are to better understand the needs, preferences and 
circumstances of the many and extremely varied groups of adolescents that exist in all societies. The 
diversity of “adolescence” cannot be overemphasized, and so combinations of social science and 
operations research are needed to first diagnose the varied needs of different adolescent groups and to 
then test and scale-up sustainable strategies that are appropriate for addressing the educational, 
informational and service needs of the different adolescents. Moreover, national HMISs urgently need to 
be strengthened so as to collect, analyze, and use data disaggregated by age and other critical 
determinants of adolescents’ FP needs.  
 
Interventions to Improve and Sustain the Quality of FP Services  
FP2020 recognizes and endorses all individuals’ right to the highest quality of care; moreover, existing 
evidence indicates that poor-quality counseling and delivery are universal barriers to initiation and 
sustained use of FP. More evidence is needed to identify feasible and acceptable interventions that 
enable and require providers to respond to their clients’ individual needs. Evidence is also needed of 
their effectiveness and sustainability in both attracting new FP users and in reducing discontinuation, as 
well as their ability to ensure that the distinct needs of vulnerable and underserved populations are 
appropriately met. Investment in context-specific operations and implementation research around quality 
improvement interventions would enable health systems to address the many method-and program-
related factors that are the most commonly cited reasons for non-use of contraception among women 
with an unmet need. A key research investment would be the strengthening of quality assurance and 
monitoring mechanisms to ensure that such improvements are standardized, routinized, and sustained.  
 
Strategies for Scaling up Effective Models of Integrated Services  
Integrating FP within other health services is an important strategy for FP2020; integrated services can 
be more accessible, acceptable, affordable and less stigmatized, and there may be greater efficiencies in 
service delivery. Evidence of the feasibility, acceptability and effectiveness of various models of FP 
integration with antenatal, delivery, postpartum and postabortion care, and with HIV services, is well-
established. Evidence of how to adapt, scale-up, and institutionalize these models within a national 
health system is lacking, however, in part because there is little experience of offering integrated services 
at scale. Prospective implementation research is needed that systematically documents strategies for 
scaling up various proven models through describing the systems-level organizational modifications (e.g. 
in commodity supplies, provider training and supervision, M&E, etc.), policy adjustments, budgetary 
reallocations, and the costs and cost-savings involved when expanding an integrated model proven 
through a small-scale pilot study.  
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Strategies for Reaching Rural Communities  
Many developing countries are still characterized by largely rural, often remote, populations. Evidence 
supports the effectiveness of CHW programs in expanding access to FP among these populations and so 
expansion of such programs is likely to feature significantly in many national FP2020 initiatives. 
Countries would benefit, however, from investments in operations and implementation research that 
would enable them to fine-tune this proven best practice to their national contexts and to rapidly roll-out 
coverage to better reach underserved and vulnerable populations. CHWs can also be important strategies 
for reaching populations living in urban informal or ‘slum’ settlements. Greater investment in policy 
analyses and health systems research would guide countries in incorporating community-level services 
into the formal health system, especially countries seeking to adapt national models that have been 
proven effective by NGOs or faith-based organizations (FBOs).  
 
Existing evidence also supports investment in expansion of a second proven strategy for reaching rural 
communities, that is, mobile outreach services, which can be an essential source of long-acting reversible 
and permanent contraception, thereby complementing the delivery of short-acting methods that 
characterizes most CHW programs. However, investment in operations and implementation research 
would help countries to rapidly adapt this strategy in both public and non-public programs.  
 
Strategies for Reaching Urban Poor Populations  
Rapid urbanization is leading to burgeoning populations of urban poor that are often more 
disadvantaged and have poorer reproductive and maternal health than the rural poor. Despite 
geographical proximity to a wide range of outlets, access to affordable and appropriate services is often 
constrained. Evidence-based strategies for reaching the rapidly growing urban poor will be critical for 
FP2020, given the scale of growth in these populations and the increasing share the urban poor will 
contribute to unmet need. Private sector pharmacies, drug sellers, and commercial retail outlets—either 
independently or within a social marketing program—have tremendous potential to complement public 
(and private) facilities in urban areas, but evidence of feasibility, affordability, quality of care, and 
effectiveness in engaging with the private sector to reach the urban poor are lacking. A “total market” 
approach, including a range of research activities to assess and analyze the situation and opportunities, 
would be particularly appropriate when planning and developing strategies to reach the full spectrum of 
slum dwellers.  
 
Techniques for Defining and Shaping Contraceptive Markets to Improve Availability and 
Access  
Market shaping will feature prominently in FP2020 and is a process that requires much more evidence of 
contraceptive demand and use dynamics and of commodity market dynamics than is currently available – 
or than can be generated with existing research methods. Developments in research methods are needed 
urgently, by drawing initially from the experiences of organizations and donors undertaking market 
shaping in other health fields (e.g. HIV, malaria) and adapting these techniques to contraceptive market 
development approaches. Investments in building the capacity of FP researchers to understand and 
apply these methods, and of health system planners to understand and use the data generated from 
market shaping analyses, are needed immediately if this key element of FP2020 is to be successful.  
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Innovative Financing Mechanisms to Expand Access and Increase Affordability  
The impressive commitments of financial and other resources for FP2020 can only be successful if the 
systems in which they are invested function efficiently and ensure that a full range of affordable 
contraceptive options are available to as wide a population as possible. PBF is emerging as a potential 
complement to conventional input-based public-sector financing for health systems generally, but little 
evidence exists concerning PBF of FP services. Investment in operations and implementation research 
to evaluate and compare the cost, effectiveness and equity effects of various PBF models in the public 
and non-public sectors with conventional input-based financing models is essential and urgently needed. 
As most national health systems will continue to finance FP services through input-based financing, 
however, (at least during the lifetime of FP2020), research is also needed to better understand these 
financing mechanisms and to identify interventions to improve their functioning and efficiency.  
 
As contraceptive markets continue to diversify, the price of contraceptive commodities, both to 
governments and to users, will become an increasingly important factor. Further evidence is needed, 
which can be researched with existing methods, about users’ willingness and ability to pay, and about the 
role of method pricing in determining access for vulnerable and marginalized populations as well as the 
method mix available, especially in public sector programs.  
 
Strategies for Advocacy and Accountability  
Two major and interrelated thrusts of FP2020, for which clear conceptualizations are lacking and there is 
little research-based evidence of what is effective, are interventions for advocacy (to ensure that 
commitments are actually made and invested appropriately) and for accountability (to empower 
communities to engage meaningfully in FP2020-supported initiatives and to institutionalize this 
engagement). Given the centrality to the objectives of FP2020 of both advocacy and accountability, 
investments in developing an evidence base for both types of interventions should be an urgent priority. 
Case studies of existing experiences, operations research that develops and tests various interventions, 
and rigorous M&E mechanisms to document their implementation and assess their impact would be 
helpful in building this evidence base.  
 
Understanding the Dynamics of Contraceptive Decision-Making and Use  
To reduce unmet need effectively, a national program first needs to fully understand the reasons why 
women, girls, and their partners do or do not use contraception when they are at risk of an unintended 
pregnancy, and how these reasons vary among different population groups. Country-specific social 
science research is needed to analyze these reasons and their determining factors so as to identify which 
delivery strategies, financing mechanisms, demand generation strategies or commodity mix options 
would best address the various barriers to use, disaggregated by key population groups. Moreover, 
methodological developments are needed to better measure and explain socio-behavioral determinants 
of demand and use, including risk perception, ambivalence, and fear, both for the women and their 
partners. This research is particularly needed in settings and for populations marked by low literacy rates, 
poverty, and low contraceptive prevalence.  
 
Recent evidence reinforces the major contribution to unmet need and unintended pregnancy of 
discontinuation and method failure or inconsistent/incorrect use of contraceptives. Context-specific 
social science and acceptability research are needed to inform programs of the reasons for method 
discontinuation or failure so that interventions can be developed and tested through operations research 
to reduce the causative factors. Such evidence can also inform market shaping (to identify appropriate 
method mixes for particular populations) and product development (to guide new product designs).  
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Building Capacity and Improving Methods to Generate and Use Evidence on FP  
The human resources needed to undertake the research that will address these evidence gaps remains 
highly concentrated in northern countries and organizations; a substantial and immediate investment in 
building southern-based research capacity is critical if evidence generation is to be institutionalized and 
sustained in the countries that need the evidence. Moreover, some evidence gaps will need new or 
adapted measures and research methods, which will require investment in their development, validation, 
and testing in a variety of contexts. Additionally, despite the heavy reliance on national HMISs for data 
to evaluate FP services, virtually all HMISs in developing countries generate data of dubious validity; 
investment is urgently needed to strengthen HMISs in most developing countries, especially through 
computerization, as well as the capacity of program managers to extract and use the data reported.  
 
While increasing emphasis on evidence-informed decision-making by donors and national health systems 
is welcomed and strongly endorsed, the capacity of decision-makers, in both developing and developed 
countries, to interpret and use research-based evidence is mixed. In particular, there is much confusion 
and a lack of agreement about procedures for collating and synthesizing evidence from various sources, 
including research, for formulating recommendations for programming. For guidance in “best practices” 
to be recommended, there needs to be greater consensus among decision-makers, especially in donor 
and policymaking organizations, on what constitutes high-quality evidence and which types of evidence 
provide the greatest degree of confidence for making strong recommendations. Uncertainty over the 
credibility of evidence not generated through RCTs and the role of experiential evidence are just two of 
the factors confusing the role of evidence in programmatic recommendations.  
 
Looking Ahead 
Research shows that through high-quality voluntary FP programs, governments can reduce fertility and 
generate substantial improvements in health, wealth, human rights, and education. Family planning 
programs for the 21st century will require thoughtful design—engaging both public and private sectors—
to meet the growing need for safe and effective FP services. Moreover, the combination of substantial 
commitments to FP2020 from national governments and a wide range of development partners presents 
a major challenge in coordinating efforts by multiple actors with different expectations and ways of 
functioning.  
A new generation of women and men will be entering their reproductive years during FP2020; they 
represent future global markets, future parents, and future FP users. Efforts to provide timely, accurate, 
and culturally appropriate information can contribute to the RH of many. The challenges ahead for FP 
programs will be to increase overall access while reducing inequities in individuals’ ability to use a 
method of their choice, particularly inequities due to poverty, gender, age, and marital status. This 
requires investments in research that not only informs health systems strengthening but also empowers 
girls and women to make and act upon their own best decisions about pregnancy and childbearing. 
These challenges need to be addressed in the context of constantly increasing population sizes in most 
developing countries, necessitating additional investments just to sustain existing levels of need.  
We must seize the moment and “capitalize on the growing momentum to establish family planning 
programs as accepted, expected, and routine elements of national health care systems worldwide” 
(Bongaarts et al. 2012).  
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Glossary of Terms and Definitions  
Contraceptive prevalence  
The percentage of women who are currently using, or whose sexual partner is currently using, at least 
one method of contraception, regardless of the method used.  It is usually reported for married or in-
union women aged 15 to 49. 
(http://www.who.int/reproductivehealth/topics/family_planning/contraceptive_prevalence/en/)  
Market development approaches (MDAs) to reproductive health are initiatives that work toward 
enhanced financial sustainability, improved access and expanded choice. The term “market 
development approach” encompasses a very broad set of approaches to health care delivery, but by 
definition involves the commercial sector.  
Market shaping  
Market shaping (in this context) is defined as supporting the efficient procurement of quality 
commodities while ensuring sustainable supply at affordable prices to eligible countries. 
(http://www.gavialliance.org/library/gavi-documents/white-papers/market-shaping--strategic-
considerations-for-a-healthy-vaccine-marketplace  
Market segmentation  
Market segmentation is the process of dividing the total market into smaller subsets (segments) that 
have similar characteristics, needs, or behaviors. Market segmentation analysis looks at current patterns 
of  demand and use for RH commodities and the characteristics of users—socioeconomic, 
sociocultural, and behavioral—in order to find better and more efficient ways to meet existing demand 
or generate increased demand. 
(http://deliver.jsi.com/dhome/topics/policy/csinitiatives/marketsegmentation  
Market segmentation strategies are used by businesses to divide their customers into distinct groups 
based on different factors, such as income, and to target their products accordingly. In FP, market 
segmentation is used to divide the FP market into groups based on choice of method and provider and 
to match clients with sources based on need and ability to pay.  
http://www.fhi.org/en/RH/Pubs/booksReports/fpfinancing/brief3.htm  
Population momentum  
The tendency for population growth to continue beyond the time that replacement-level fertility has 
been achieved because of the relatively high concentration of people in the childbearing years. 
(http://www.prb.org/Educators/Resources/Glossary.aspx)  
Social determinants  
The social determinants of health are the conditions in which people are born, grow, live, work and age, 
including the health system. These circumstances are shaped by the distribution of money, power and 
resources at global, national and local levels. The social determinants of health are mostly responsible for 
health inequities—the unfair and avoidable differences in health status seen within and between 
countries. (http://www.who.int/social_determinants/en/)  
Inter-related social and economic factors that influence health. Social determinants of health include, but 
are not limited to: socioeconomic status, discrimination, housing, physical environment, food security, 
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child development, culture, social support, healthcare services, transportation, working conditions, and 
democratic participation.  
Structural interventions  
Structural interventions refer to public health interventions that promote health by altering the structural 
context within which health is produced and reproduced. Structural interventions differ from many 
public health interventions in that they locate, often implicitly, the cause of public health problems in 
contextual or environmental factors that influence risk behavior, or other determinants of infection or 
morbidity, rather than in characteristics of individuals who engage in risk behaviors. 
(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473169/)  
Interventions designed to remove barriers and incorporate facilitators of an individual’s HIV prevention 
(health-seeking, disease prevention) behaviors. These barriers or facilitators include physical, social, 
cultural, organizational, community, economic, legal, or policy circumstances or actions that directly or 
indirectly affect an individual’s ability to avoid (disease, poor health) exposure to HIV. 
(http://www.cdc.gov/hiv/topics/evaluation/health_depts/guidance/glossary.htm)  
Structural approaches include social, economic, and political interventions that can improve public 
health outcomes by increasing the willingness and ability of individuals to practice prevention. 
(http://www.aidstarone.com/focus_areas/prevention/pkb/structural_interventions/overview_stru 
ctural_approaches_hiv_prevention)  
Total fertility rate  
The number of children who would be born per woman (or per 1,000 women) if she/they were to 
pass through the childbearing years bearing children according to a current schedule of age-specific 
fertility rates. The TFR is the most widely used fertility measure in program impact evaluations for two 
main reasons: (1) it is unaffected by differences or changes in age-sex composition, and (2) it provides 
an easily understandable measure of hypothetical completed fertility. 
(http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/fertility/total-fertility-rate)  
The average number of live births a woman would have by age 50 if she were subject, throughout her 
life, to the age-specific fertility rates observed in a given year. Its calculation assumes that there is no 
mortality. (http://www.un.org/esa/sustdev/natlinfo/indicators/methodology_sheets/demographics/ 
total_fertility_rate.pdf)  
Total market approach  
Having the public and nonprofit sectors provide subsidized services for needy consumers while 
maintaining sustainable commercial provision for consumers who are able to pay is often referred to as a 
“total market” or “whole market” approach. 
(http://www.rhsupplies.org/fileadmin/user_upload/MDA_Documents/Total_Market_Initiatives_f 
or_Reproductive_Health.pdf)  
DFID defines a TMA as a process to “assess the characteristics of existing and likely future markets, 
and to define the comparative advantage of commercial, social marketing, non-governmental 
organization, and public sector actors in terms of competence and value for money in delivering a range 
of products or services to different market segments, including the poorest. It can enable closer and 
more structured linkages with commercial, public and non-governmental organizational sectors and aid 
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the gradual shifting of consumers with sufficient purchasing power out of the public sector.” 
(http://shopsproject.org/sites/default/files/resources/5010_file_Total_Market_Approach_honey 
manp3.pdf  
Unmet need  
The percent with an unmet need for family planning is the number of women with unmet need for 
family planning expressed as a percentage of women of reproductive age who are married or in a union. 
Women with unmet need are those who are fecund and sexually active but are not using any method of 
contraception, and report not wanting any more children or wanting to delay the birth of their next child. 
(http://www.who.int/reproductivehealth/topics/family_planning/unmet_need_fp/en/index.html)  
Youth bulge  
A high proportion of 15-to-29 year olds relative to the adult population. 
(http://blogs.worldbank.org/developmenttalk/youth-bulge-a-demographic-dividend-or-a-
demographic-bomb-in-developing-countries)  
The youth bulge is a common phenomenon in many developing countries, and in particular, in the least 
developed countries. It is often due to a stage of development where a country achieves success in 
reducing infant mortality but mothers still have a high fertility rate. The result is that a large share of the 
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